CD6 and Syntaxin Binding Protein 6 Variants and Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis

Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response

(2011) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

(2011) Lilian Soto et al.   CLINICAL RHEUMATOLOGY

Genetic and genomic predictors of anti-TNF response

(2011) Rita Prajapati et al.   PHARMACOGENOMICS

Identification of Nine Novel Loci Associated with White Blood Cell Subtypes in a Japanese Population

(2011) Yukinori Okada et al.   PLoS Genetics

Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

(2010) R. J. L. Tan et al.   ANNALS OF THE RHEUMATIC DISEASES

Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients

(2010) L. R. Coulthard et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF B signalling pathways

(2010) C. Potter et al.   ANNALS OF THE RHEUMATIC DISEASES

Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci

(2010) Darren Plant et al.   ARTHRITIS AND RHEUMATISM

CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction

(2010) P. Nair et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Small insertions and deletions (INDELs) in human genomes

(2010) J. M. Mullaney et al.   HUMAN MOLECULAR GENETICS

The discovery of human genetic variations and their use as disease markers: past, present and future

(2010) Chee Seng Ku et al.   JOURNAL OF HUMAN GENETICS

Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response

(2010) Catherine Potter et al.   Pharmacogenetics and Genomics

DANBIO--powerful research database and electronic patient record

(2010) M. L. Hetland   RHEUMATOLOGY

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

(2010) Vappu Rantalaiho et al.   ARTHRITIS RESEARCH & THERAPY

Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study

(2010) Marian Suarez-Gestal et al.   ARTHRITIS RESEARCH & THERAPY

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

(2009) Merete Lund Hetland et al.   ARTHRITIS AND RHEUMATISM

Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics

(2009) N T Hansen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions

(2009) Robert M Plenge et al.   CURRENT OPINION IN RHEUMATOLOGY

Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients

(2009) John D. Bowes et al.   Pharmacogenetics and Genomics

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis

(2008) E J M Toonen et al.   ANNALS OF THE RHEUMATIC DISEASES

Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure

(2008) U M. Dohn et al.   ANNALS OF THE RHEUMATIC DISEASES

Influence of variants of Fc  receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor   therapy in rheumatoid arthritis

(2008) J D Canete et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

(2008) James R. Maxwell et al.   HUMAN MOLECULAR GENETICS